Champions Oncology outlines fiscal 2027 plan with Corellia fully funded as it reports $59.4M revenue and $1.6M adjusted EBITDA (NASDAQ:CSBR)July 27, 2026
Share Facebook Twitter LinkedIn Pinterest Email Odds of Strait of Hormuz opening plunge on prediction markets
Champions Oncology outlines fiscal 2027 plan with Corellia fully funded as it reports $59.4M revenue and $1.6M adjusted EBITDA (NASDAQ:CSBR)July 27, 2026
